MyCartis Competitors and Similar CompaniesClear all
MyCartis's competitors and similar companies include OncoLens, Predicine and DEM BioPharma.
 OncoLens OncoLens (also known as Lynkcare) is a company that develops an AI-based oncology care platform. |  DEM BioPharma DEM BioPharma is a company that works to eradicate cancer by targeting new checkpoints in the innate immune system. | |||
Founding Date | Founding Date 2014 | Founding Date 2016 | Founding Date 2015 | Founding Date 2022 |
Type | Type Private | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Gent, BE HQ | Locations Atlanta, US HQ | Locations Hayward, US HQ Houston, US Schaumburg, US | Locations HQ |
Employees | Employees 3 | Employees 287% decrease | Employees 981% increase | Employees 25 |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 2.5m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 70m (about 4 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 7.2m | Total funding raised N/A | Total funding raised $ 70m |
For sources of this data, please see the company profile
View Company Profiles
OncoLens
HQ
Atlanta, US
Employees
28↓ 7% decrease
OncoLens (also known as Lynkcare) is a company that develops an AI-based oncology care platform.
View company
Predicine
HQ
Hayward, US
Employees
98↑ 1% increase
Predicine is a company developing a platform for molecular insights into cancer genomics.
View companyDEM BioPharma
HQ
Employees
25
DEM BioPharma is a company that works to eradicate cancer by targeting new checkpoints in the innate immune system.
View company